Bain Capital, LP is one of the world’s leading private multi-asset alternative investment firms with approximately $150 billion of assets under management that creates lasting impact for our investors, teams, businesses, and the communities in which we live. Since our founding in 1984, we’ve applied our insight and experience to organically expand into several asset classes including private equity, credit, public equity, venture capital and real estate. We leverage our shared platform to capture cross-asset class opportunities in strategic areas of focus. With offices on four continents, our global team aligns our interests with those of our investors for lasting impact.

Bain Capital Investor Portal Please log in to access your account information. If you have any questions regarding your account, please contact

Dylan Goldstein

Dylan Goldstein

Life Sciences


Mr. Goldstein joined Bain Capital Life Sciences in 2019. He is an Associate.
Prior to joining Bain Capital, Mr. Goldstein worked in investment banking at MTS Health Partners. At MTS, Mr. Goldstein specialized in mergers and acquisitions and equity financings across the biotechnology, pharmaceutical and healthcare services sectors.


Mr. Goldstein graduated summa cum laude from the Roy and Diana Vagelos Program at the University of Pennsylvania, where he earned both a B.A. in Cognitive Neuroscience and a B.S. in Economics with a concentration in Finance.